Ara
Toplam kayıt 2, listelenen: 1-2
Recommendations to balance benefits and risks of thromboprophylaxis and to avoid central venous-access devices during first-line chemotherapy in men with metastatic germ cell tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
(Elsevier, 2021)
Recent randomized controlled trials have assessed the risksand benefits of thromboprophylaxis in ambulatory cancerpatients receiving chemotherapy and reported a relativerisk reduction of 30–60% in venous thromboembolic ...
Imaging and technologies for prostate cancer. Where are we now-where do we go?
(Springer, 2021)
We have been witnessing rapid advances in the diagnosis and treatment of prostate cancer. While some approaches have matured, others are still in their infancy. We have learned that Active Surveillance is safe in patients ...